Adva Levy‐Barda
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- COVID-19 and healthcare impacts
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 3
- Ubiquitin and proteasome pathways 2
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Amos Stemmer (2 shared papers)Alona Zer (3 shared papers)Boaz Tadmor (1 shared paper)Neta Moskovits (2 shared papers)Noa Eliakim‐Raz (2 shared papers)Baruch Brenner (2 shared papers)Haim Ben‐Zvi (2 shared papers)Shlomit Yust‐Katz (2 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Journal of Clinical Oncology (1 paper)Molecular Biology Reports (1 paper)Molecular Oncology (1 paper)Neuro-Oncology (1 paper)
- Partner nations
- IsraelUnited StatesCanada
In The Last Decade
Adva Levy‐Barda
13 papers receiving 334 citations
Peers
Comparison fields: 5 of 47
- Infectious Diseases 120
- Oncology 123
- Health 17
- Molecular Biology 123
- Cell Biology 27
Countries citing papers authored by Adva Levy‐Barda
This map shows the geographic impact of Adva Levy‐Barda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adva Levy‐Barda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adva Levy‐Barda more than expected).
Fields of papers citing papers by Adva Levy‐Barda
This network shows the impact of papers produced by Adva Levy‐Barda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adva Levy‐Barda. The network helps show where Adva Levy‐Barda may publish in the future.
Co-authors
The 25 scholars most cited alongside Adva Levy‐Barda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 173 | |
| 2 | 2011 | 50 | |
| 3 | 2018 | 44 | |
| 4 | 2021 | 23 | |
| 5 | 2017 | 11 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 4 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 3 | |
| 12 | 2024 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2023 | 0 |
About Adva Levy‐Barda
Adva Levy‐Barda is a scholar working on Molecular Biology, Infectious Diseases, Genetics, Cell Biology and Plant Science, having authored 14 papers that have together received 337 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (3 papers), Cancer Genomics and Diagnostics (2 papers), Ubiquitin and proteasome pathways (2 papers), Microtubule and mitosis dynamics (2 papers), Glioma Diagnosis and Treatment (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Infectious Diseases (120 citations), Oncology (123 citations), Health (17 citations), Molecular Biology (123 citations) and Cell Biology (27 citations). Adva Levy‐Barda has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Amos Stemmer, Alona Zer, Boaz Tadmor, Neta Moskovits, Noa Eliakim‐Raz, Baruch Brenner, Haim Ben‐Zvi, Shlomit Yust‐Katz, Salomon M. Stemmer and Alexandra Benouaich‐Amiel. Their work appears in journals such as Frontiers in Immunology, Journal of Clinical Oncology, Molecular Biology Reports, Molecular Oncology and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.